Walt Disney Co vs Enveric Biosciences Inc — how do they compare? Walt Disney Co trades at $95.99 (market cap $166.71B), while Enveric Biosciences Inc trades at $1.25 (market cap $5.36M). The key difference: Walt Disney Co is far larger — about 31102.6× Enveric Biosciences Inc's market cap, and Walt Disney Co pays a 1.56% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| DIS | ENVB | |
|---|---|---|
Market Cap | $166.71B | $5.36M |
Volume | 7,546,013 | — |
Sector | Media | Health |
52-Week High | $122.94 | $17.40 |
52-Week Low | $92.40 | $1.28 |
Enterprise Value | $208.38B | $449.11K |
Dividend Yield | 1.56% | — |
Signals from Pluang's Aura AI — not financial advice
Disney (DIS) trades at $95.87, up 0.25% with a P/E of 15.36 and strong earnings beats in recent quarters. The company shows robust fundamentals with $94.43B revenue and $12.40B net income in 2025, though technical indicators signal bearish momentum. Recent news highlights advertising opportunities with major events and regulatory challenges with the FCC.
Outlook remains positive with analyst consensus at $125.60 target, representing 31% upside. Key opportunities include sports broadcasting rights and theme park recovery, while risks involve box office performance and regulatory pressures. The stock offers value with improving profitability and strong cash flow generation.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
The Walt Disney Company is an entertainment company with operations in media networks, park experiences & consumer products, studio entertainment and Direct-to-Consumer networks and channels. The Company serves customers worldwide.
Read more on DIS →Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →